The Federal Trade Commission is stepping up its crackdown on so-called "junk ... on," FTC Chair Lina Khan said. The agency sent letters to 10 companies, warning that their patent listings were ...
The Federal Trade Commission says drug makers are gaming the system in order to keep drug prices high by filing what it ...
Gabriel: If drug manufacturers don’t remove their junk patent listings, they’ll open themselves up to antitrust lawsuits, and ...
But other companies argue that the FTC’s accusation that their patents are junk isn’t accurate. Gabriel: If drug manufacturers don’t remove their junk patent listings, they’ll open themselves up to ...
the FTC highlighted specifically its disputes of so-called “junk patent listings” for “blockbuster” weight loss medications. To date, the FTC’s Orange Book patent disputes have been ...
FTC’s latest action targets more than 300 Orange Book patent listings across 10 different companies, which brings the total to more than 400 patent listings across 14 companies and should send a ...
The FTC oversees consumer protections ... Faust: So with respect to these listings, which some people call "junk patents," it makes total sense when you're looking at something like some part ...
The U.S. Federal Trade Commission (FTC) announced last week that it is, for the second time, disputing hundreds of “junk” patents ... “By filing bogus patent listings, pharma companies ...